Dna Brands Stock Performance
| DNAX Stock | USD 0.0001 0.00 0.00% |
The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNA Brands are completely uncorrelated.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in DNA Brands are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, DNA Brands showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 0.15 | |
| Total Cashflows From Investing Activities | 1000 K |
DNA |
DNA Brands Relative Risk vs. Return Landscape
If you would invest 0.01 in DNA Brands on November 12, 2025 and sell it today you would earn a total of 0.00 from holding DNA Brands or generate 0.0% return on investment over 90 days. DNA Brands is currently generating 29.5082% in daily expected returns and assumes 181.0564% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than DNA, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
DNA Brands Target Price Odds to finish over Current Price
The tendency of DNA Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 43.0 |
Based on a normal probability distribution, the odds of DNA Brands to move above the current price in 90 days from now is about 43.0 (This DNA Brands probability density function shows the probability of DNA Pink Sheet to fall within a particular range of prices over 90 days) .
DNA Brands Price Density |
| Price |
Predictive Modules for DNA Brands
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DNA Brands. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.DNA Brands Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. DNA Brands is not an exception. The market had few large corrections towards the DNA Brands' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DNA Brands, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DNA Brands within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.000017 | |
Ir | Information ratio | 0.00 |
DNA Brands Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DNA Brands for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DNA Brands can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| DNA Brands is way too risky over 90 days horizon | |
| DNA Brands has some characteristics of a very speculative penny stock | |
| DNA Brands appears to be risky and price may revert if volatility continues | |
| DNA Brands currently holds 2 M in liabilities. DNA Brands has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist DNA Brands until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Brands' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Brands' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 249.01 K. Net Loss for the year was (1.25 M) with profit before overhead, payroll, taxes, and interest of 249.01 K. | |
| DNA Brands currently holds about 499 in cash with (1.1 M) of positive cash flow from operations. |
DNA Brands Fundamentals Growth
DNA Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of DNA Brands, and DNA Brands fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DNA Pink Sheet performance.
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Cash And Equivalents | 499 | |||
| Total Debt | 2 M | |||
| Book Value Per Share | (0.92) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | 0.02 X | |||
| Total Asset | 327 K | |||
| Retained Earnings | (30.44 M) | |||
| Current Asset | 319 K | |||
| Current Liabilities | 3.43 M |
About DNA Brands Performance
Evaluating DNA Brands' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if DNA Brands has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DNA Brands has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about DNA Brands performance evaluation
Checking the ongoing alerts about DNA Brands for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DNA Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DNA Brands is way too risky over 90 days horizon | |
| DNA Brands has some characteristics of a very speculative penny stock | |
| DNA Brands appears to be risky and price may revert if volatility continues | |
| DNA Brands currently holds 2 M in liabilities. DNA Brands has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist DNA Brands until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Brands' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Brands' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 249.01 K. Net Loss for the year was (1.25 M) with profit before overhead, payroll, taxes, and interest of 249.01 K. | |
| DNA Brands currently holds about 499 in cash with (1.1 M) of positive cash flow from operations. |
- Analyzing DNA Brands' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DNA Brands' stock is overvalued or undervalued compared to its peers.
- Examining DNA Brands' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DNA Brands' management team can have a significant impact on its success or failure. Reviewing the track record and experience of DNA Brands' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DNA Brands' pink sheet. These opinions can provide insight into DNA Brands' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.